Empire Financial Management Company’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,234
Closed -$1.59M 210
2026
Q1
$1.59M Buy
3,234
+248
+8% +$135K 0.36% 80
2025
Q4
$1.73M Buy
2,986
+66
+2% +$37.3K 0.38% 80
2025
Q3
$1.42M Buy
2,920
+188
+7% +$87.5K 0.32% 92
2025
Q2
$1.11M Buy
2,732
+384
+16% +$161K 0.32% 92
2025
Q1
$1.17M Buy
2,348
+218
+10% +$118K 0.36% 84
2024
Q4
$1.11M Buy
2,130
+166
+8% +$91.3K 0.35% 87
2024
Q3
$1.21M Buy
1,964
+38
+2% +$22.5K 0.37% 81
2024
Q2
$1.07M Buy
1,926
+542
+39% +$311K 0.35% 79
2024
Q1
$804K Buy
1,384
+238
+21% +$134K 0.27% 104
2023
Q4
$608K Buy
1,146
+101
+10% +$48.9K 0.24% 107
2023
Q3
$529K Buy
1,045
+32
+3% +$17.1K 0.23% 111
2023
Q2
$529K Buy
1,013
+90
+10% +$48.6K 0.21% 117
2023
Q1
$532K Buy
+923
New +$520K 0.22% 113

Other funds holding TMO

Empire Financial Management Company's TMO Position: Q2 2026 in Review

Empire Financial Management Company sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,234 shares — an estimated $1.59M sold.

Empire Financial Management Company first reported a position in TMO in Q1 2023 and held it in 13 quarters. The position peaked at $1.73M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Empire Financial Management Company reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Empire Financial Management Company sold 3,234 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.59M.
  • Empire Financial Management Company first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 13 quarters.
  • Empire Financial Management Company's Thermo Fisher Scientific position peaked at $1.73M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.